Carazolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263117This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29PW75S82A, chemically known as 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((1-methylethyl)amino)- but generally known as carazolol, which bears US NIH Compound Identifier 71739. Carazolol most often comes in base, glucuronide, and hydrochloride forms. European Medicines Agency schedules Carazolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06086MIG. The term CARAZOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). CARAZOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carazolol under HS 29339990 and SITC 51577. As of Q4 2014, CARAZOLOL remains the US FDA Preferred Term for this commodity. Carazolol bears US NLM identifiers UMLS ID C0054636 and NCI Concept Code C77941. SMILES: O(C1C2C3C([NH]C2CCC1)CCCC3)CC(O)CNC(C)C.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.